Breaking News

Swiss National Bank Introduces Negative Interest Rate of -0.25%
Tweet TWEET

Alkermes Announces Webcast of R&D Day on July 17, 2013

  Alkermes Announces Webcast of R&D Day on July 17, 2013

Business Wire

DUBLIN -- July 10, 2013

Alkermes plc (NASDAQ: ALKS) announced today that it will webcast its Research
and Development (R&D) Day presentation on Wednesday, July 17, 2013. The
webcast will begin at 1:00 p.m. EDT (6:00 p.m. BST). At the meeting, members
of Alkermes’ senior management will provide detailed information on the
company’s lead clinical programs, discuss its distinctive R&D strategy and
introduce new product candidates.

A live webcast of the event will be available on the Investors tab of the
company’s website at www.alkermes.com. To ensure a timely connection to the
webcast, it is recommended that users register at least 15 minutes prior to
the scheduled start. This webcast will be archived on Alkermes’ website for
one month.

Alkermes plc is a fully integrated, global biopharmaceutical company that
applies its scientific expertise and proprietary technologies to develop
innovative medicines that improve patient outcomes. The company has a
diversified portfolio of more than 20 commercial drug products and a
substantial clinical pipeline of product candidates that address central
nervous system (CNS) disorders such as addiction, schizophrenia and
depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center
in Waltham, Massachusetts; a research and manufacturing facility in Athlone,
Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington,
Ohio. For more information, please visit Alkermes’ website at
www.alkermes.com.

Contact:

Alkermes:
Eva Stroynowski, +1 781-609-6823
Corporate Communications
 
Press spacebar to pause and continue. Press esc to stop.